Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carl H June

Showing results (331-340 of 460) with videos related to

Pageof 46
Sort By:
Cancer Immunology, Immunotherapy : CII|December 25, 2012
Bi-specific TCR-anti CD3 redirected T-cell targeting of NY-ESO-1- and LAGE-1-positive tumorsEmmet McCormack, Katherine J Adams, Namir J Hassan, et al.
Blood|August 24, 2023
Exploiting the CD200-CD200R immune checkpoint axis in multiple myeloma to enhance CAR T-cell therapyYan Tang, Wei Liu, Siddhant Kadu, et al.
The New England Journal of Medicine|September 10, 2015
Chimeric Antigen Receptor T Cells against CD19 for Multiple MyelomaAlfred L Garfall, Marcela V Maus, Wei-Ting Hwang, et al.
Frontiers in Immunology|September 8, 2025
Multiplex engineering using microRNA-mediated gene silencing in CAR T cellsGiulia Golinelli, John Scholler, Audrey Roussel-Gervais, et al.
Science Translational Medicine|May 20, 2011
Massive ex vivo expansion of human natural regulatory T cells (T(regs)) with minimal loss of in vivo functional activityKeli L Hippen, Sarah C Merkel, Dawn K Schirm, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 13, 2011
National Cancer Institute's First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: summary and recommendations from the organizing committeeMichael R Bishop, Edwin P Alyea, Mitchell S Cairo, et al.
Bioengineering & Translational Medicine|June 11, 2026
Bioinspired oxidized mRNA lipid nanoparticles for ex vivo engineering of chimeric antigen receptor macrophages targeting solid tumorsAlvin J Mukalel, Tina Tylek, Hannah C Geisler, et al.
Journal for Immunotherapy of Cancer|April 13, 2026
Data-informed optimization of CAR T-cell therapy long-term follow-upBetsy Foss-Campbell, Nancy Myers, Rakesh Awasthi, et al.
American Journal of Respiratory and Critical Care Medicine|June 7, 2011
A trial of intrapleural adenoviral-mediated Interferon-α2b gene transfer for malignant pleural mesotheliomaDaniel H Sterman, Andrew Haas, Edmund Moon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 29, 2016
The Addition of the BTK Inhibitor Ibrutinib to Anti-CD19 Chimeric Antigen Receptor T Cells (CART19) Improves Responses against Mantle Cell LymphomaMarco Ruella, Saad S Kenderian, Olga Shestova, et al.
Pageof 46

Showing results (331-340 of 460) with videos related to

Sort By:
Pageof 46
Cancer Immunology, Immunotherapy : CII|December 25, 2012
Bi-specific TCR-anti CD3 redirected T-cell targeting of NY-ESO-1- and LAGE-1-positive tumorsEmmet McCormack, Katherine J Adams, Namir J Hassan, et al.
Blood|August 24, 2023
Exploiting the CD200-CD200R immune checkpoint axis in multiple myeloma to enhance CAR T-cell therapyYan Tang, Wei Liu, Siddhant Kadu, et al.
The New England Journal of Medicine|September 10, 2015
Chimeric Antigen Receptor T Cells against CD19 for Multiple MyelomaAlfred L Garfall, Marcela V Maus, Wei-Ting Hwang, et al.
Frontiers in Immunology|September 8, 2025
Multiplex engineering using microRNA-mediated gene silencing in CAR T cellsGiulia Golinelli, John Scholler, Audrey Roussel-Gervais, et al.
Science Translational Medicine|May 20, 2011
Massive ex vivo expansion of human natural regulatory T cells (T(regs)) with minimal loss of in vivo functional activityKeli L Hippen, Sarah C Merkel, Dawn K Schirm, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 13, 2011
National Cancer Institute's First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: summary and recommendations from the organizing committeeMichael R Bishop, Edwin P Alyea, Mitchell S Cairo, et al.
Bioengineering & Translational Medicine|June 11, 2026
Bioinspired oxidized mRNA lipid nanoparticles for ex vivo engineering of chimeric antigen receptor macrophages targeting solid tumorsAlvin J Mukalel, Tina Tylek, Hannah C Geisler, et al.
Journal for Immunotherapy of Cancer|April 13, 2026
Data-informed optimization of CAR T-cell therapy long-term follow-upBetsy Foss-Campbell, Nancy Myers, Rakesh Awasthi, et al.
American Journal of Respiratory and Critical Care Medicine|June 7, 2011
A trial of intrapleural adenoviral-mediated Interferon-α2b gene transfer for malignant pleural mesotheliomaDaniel H Sterman, Andrew Haas, Edmund Moon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 29, 2016
The Addition of the BTK Inhibitor Ibrutinib to Anti-CD19 Chimeric Antigen Receptor T Cells (CART19) Improves Responses against Mantle Cell LymphomaMarco Ruella, Saad S Kenderian, Olga Shestova, et al.
Pageof 46